Pulsli Inc reposted this
Interesting analysis of remote monitoring and cost reduction.
Pulsli is on a mission to improve the quality of life for Congestive Heart Failure patients using a clinically validated and patented solution that can be widely deployed thanks to its cost effectiveness and noninvasiveness. Our technology combined with AI-based pattern recognition can detect an imminent fluid overload in-time to enable corrective action to be taken in order to avoid costly hospitalizations. Pulsli focuses on accessibility, ease of use and patient engagement, and is set to deliver higher efficacy to medical professionals.
External link for Pulsli Inc
10089 WILLOW CREEK RD
200
SAN DIEGO, California 92131, US
Pulsli Inc reposted this
Interesting analysis of remote monitoring and cost reduction.
Pulsli is excited to launch it's survey investigating product market fit and showcasing our ground breaking innovation in Remote Patient Monitoring. We invite all medical professionals to participate in our survey and provide their feedback to guide future product design and prioritization. https://lnkd.in/gtKx3fk5 Also make sure to check the personal invite by our CMO, Andrew J. Sauer, MD and Harvey Castro, MD, MBA.: https://lnkd.in/gv8MGyQc Andrew J. Sauer, MD, Harvey Castro, MD, MBA., Ioannis Mastoris, MD, FACC,Boris Krajacic, MD, MSc , Connie Lewis, Tina Ivovic, Vlad Zah, Reuben Lawson, Karen Friedrichs, Catherine Kingsford, GAICD, Sasha Banjac, Rok Ursic
Pulsli Inc reposted this
More optimism for contemporary remote monitoring involving relatively simple technology and human touch of nursing contacts for patients with heart failure. But we should be careful interpreting these observational data. We need more studies, particularly involving randomization.
🎉 Exciting News from Pulsli! 🎉 We are thrilled to announce that Pulsli has been selected as one of the 200 out of 1,400 applicants to progress in the prestigious MedTech Innovator (https://lnkd.in/d4FGjn5)! Our innovative, non-invasive, cost-efficient remote patient self-monitoring technology, which can quantify fluid buildup in CHF patients, has been recognized by experts involved in the selection process. Pulsli is excited to pitch on April 2nd in Washington D.C. and progress to the finals, where it will compete against 49 other finalists. This recognition is a testament to our team's hard work, dedication, and commitment to revolutionizing heart failure management. We are proud to be at the forefront of medtech innovation, bringing hope and improved quality of life to those affected by this challenging condition. #Pulsli #MedTechInnovator #HeartFailure #Innovation #HealthTech
Wohoo! Pulsli is one of the top 12 semifinalist in SDAC VI San Diego Angel Conference. Excited to present the 10min pitch on March 13th!